Both we and other investigators found that several phytochemicals, including EGCG, that have antitumor activity can suppress the activation of AP-1 and NF-κB, while also inhibiting the expression of target molecules cyclin D1 and COX-2 in cancer cells [2, 10, 11, 13, 15]. This evidence concerns the gene FOS and cancer.